JP2007500168A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500168A5
JP2007500168A5 JP2006521532A JP2006521532A JP2007500168A5 JP 2007500168 A5 JP2007500168 A5 JP 2007500168A5 JP 2006521532 A JP2006521532 A JP 2006521532A JP 2006521532 A JP2006521532 A JP 2006521532A JP 2007500168 A5 JP2007500168 A5 JP 2007500168A5
Authority
JP
Japan
Prior art keywords
compound according
medicament
prevention
treatment
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006521532A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007500168A (ja
Filing date
Publication date
Priority claimed from ES200301806A external-priority patent/ES2222828B1/es
Application filed filed Critical
Publication of JP2007500168A publication Critical patent/JP2007500168A/ja
Publication of JP2007500168A5 publication Critical patent/JP2007500168A5/ja
Pending legal-status Critical Current

Links

JP2006521532A 2003-07-30 2004-07-29 1−スルホニルインドール誘導体、それらの調製及び5−ht6リガンドとしてのそれらの使用 Pending JP2007500168A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200301806A ES2222828B1 (es) 2003-07-30 2003-07-30 Derivados de 1-sulfonilindoles, su preparacion y su aplicacion como medicamentos.
PCT/EP2004/008516 WO2005013974A1 (en) 2003-07-30 2004-07-29 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands

Publications (2)

Publication Number Publication Date
JP2007500168A JP2007500168A (ja) 2007-01-11
JP2007500168A5 true JP2007500168A5 (enExample) 2007-09-13

Family

ID=34130540

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006521532A Pending JP2007500168A (ja) 2003-07-30 2004-07-29 1−スルホニルインドール誘導体、それらの調製及び5−ht6リガンドとしてのそれらの使用

Country Status (21)

Country Link
US (1) US7655690B2 (enExample)
EP (1) EP1648443B1 (enExample)
JP (1) JP2007500168A (enExample)
KR (1) KR20060056347A (enExample)
CN (1) CN1863527A (enExample)
AR (1) AR045159A1 (enExample)
AT (1) ATE473738T1 (enExample)
AU (1) AU2004262490A1 (enExample)
BR (1) BRPI0413062A (enExample)
CA (1) CA2533996A1 (enExample)
DE (1) DE602004028125D1 (enExample)
EC (1) ECSP066330A (enExample)
ES (2) ES2222828B1 (enExample)
IL (1) IL172956A0 (enExample)
MX (1) MXPA06001229A (enExample)
NO (1) NO20060342L (enExample)
PE (1) PE20050726A1 (enExample)
RU (1) RU2006105782A (enExample)
TW (1) TW200509908A (enExample)
WO (1) WO2005013974A1 (enExample)
ZA (1) ZA200600427B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246721B1 (es) * 2004-08-10 2007-03-16 Laboratorios Del Dr. Esteve, S.A. Compuestos indolicos sustituidos, su preparacion y su uso como medicamentos.
EP1632491A1 (en) * 2004-08-30 2006-03-08 Laboratorios Del Dr. Esteve, S.A. Substituted indole compounds and their use as 5-HT6 receptor modulators
CN101247853B (zh) 2005-04-13 2014-11-12 轴突公司 具有nos抑制活性的取代的吲哚化合物
AU2007217040A1 (en) 2006-02-17 2007-08-30 Memory Pharmaceuticals Corporation Compounds having 5-HT6 receptor affinity
US7989447B2 (en) 2006-04-13 2011-08-02 Neuraxon, Inc. 1,5 and 3,6-substituted indole compounds having NOS inhibitory activity
WO2007138611A1 (en) * 2006-05-30 2007-12-06 Suven Life Sciences Limited 3-(heterocyclyl)-n-(arylsulfonyl)indole derivatives as functional 5-ht6 ligands
EP2046741B1 (en) * 2006-07-03 2012-10-31 Proximagen Ltd. Indoles as 5-ht6 modulators
JP2010515674A (ja) * 2007-01-08 2010-05-13 スベン ライフ サイエンシズ リミティド 5−(ヘテロシクリル)アルキル−n−(アリールスルホニル)インドール化合物および5−ht6リガンドとしてのそれらの使用
EP1947085A1 (en) * 2007-01-19 2008-07-23 Laboratorios del Dr. Esteve S.A. Substituted indole sulfonamide compounds, their preparation and use as medicaments
CA2683124C (en) 2007-05-03 2012-09-25 Suven Life Sciences Limited Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
ATE499099T1 (de) * 2007-07-19 2011-03-15 Esteve Labor Dr Substituierte tetrahydro- chinolinsulfonamidverbindungen, ihre herstellung und ihre verwendung als medikamente
EP2018861A1 (en) * 2007-07-26 2009-01-28 Laboratorios del Dr. Esteve S.A. 5HT6-Ligands such as sulfonamide derivatives in drug-induced weight-gain
ATE495737T1 (de) 2007-08-01 2011-02-15 Esteve Labor Dr Kombination von mindestens zwei 5-ht6-liganden
JP2011503120A (ja) 2007-11-16 2011-01-27 ニューラクソン,インコーポレーテッド 内臓痛を治療するためのインドール化合物および方法
US8318725B2 (en) 2008-09-17 2012-11-27 Suven Life Sciences Limited Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
ES2424036T3 (es) 2008-09-17 2013-09-26 Suven Life Sciences Limited Compuestos de amina de arilsulfonamida y su uso como ligandos de 5-HT6
CN104276993B (zh) * 2013-07-12 2019-03-15 广东东阳光药业有限公司 吲哚衍生物及其在药物上的应用
EP3166924B1 (en) 2014-07-08 2019-02-20 Sunshine Lake Pharma Co., Ltd. Aromatic heterocyclic derivatives and pharmaceutical applications thereof
CN104529866A (zh) * 2014-12-12 2015-04-22 广东东阳光药业有限公司 吲哚类衍生物及其在药物上的应用
US20190336585A1 (en) * 2018-05-03 2019-11-07 John Lawrence Mee Method for sustainable human cognitive enhancement
US20190390193A1 (en) * 2018-06-23 2019-12-26 John Lawrence Mee Reversible method for sustainable human cognitive enhancement

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120749A (en) * 1991-02-20 1992-06-09 Abbott Laboratories Platelet activating antagonists
GB9820113D0 (en) * 1998-09-15 1998-11-11 Merck Sharp & Dohme Therapeutic agents
MXPA02001473A (es) 1999-08-12 2003-07-21 Nps Allelix Corp Azaindoles que tienen afinidad con el receptor de serotonina.
ATE327232T1 (de) * 2000-12-22 2006-06-15 Wyeth Corp Heterozyklylalkylindole oder -azaindole als 5- hydroxytryptamine-6 liganden
DK1355904T3 (da) * 2000-12-22 2007-10-15 Wyeth Corp Heterocyclindazol- og -azaindazolforbindelser som 5-hydroxytryptamin-6-ligander
AU2002236730B2 (en) * 2001-01-30 2006-06-15 Eli Lilly And Company Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-HT6 receptor
EP1438045B1 (en) * 2001-10-23 2007-02-14 Biovitrum Ab Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake
TW200301251A (en) * 2001-12-20 2003-07-01 Wyeth Corp Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands

Similar Documents

Publication Publication Date Title
JP2007500168A5 (enExample)
RU2006105782A (ru) Производные 1-сульфонилиндола, их получение и их применение в качестве лигандов 5-нт-6
JP2004527467A5 (enExample)
TWI720272B (zh) 雜芳基苯氧基苯甲醯胺kappa類鴉片配體
CA2466965A1 (en) Sulphonamide derivatives, their preparation and use as medicaments
CN100352437C (zh) 哌嗪衍生物、它们的制备方法及其在制备治疗中枢神经系统(cns)疾病的药物中的应用
JP2005518414A5 (enExample)
JP2020523388A5 (enExample)
JP2010538001A5 (enExample)
JP2008528674A (ja) 治療効果を有する新規化合物
JP2005513016A5 (enExample)
RU2006105777A (ru) Индол-6-ильные сульфонамидные производные, их получение и их применение в качестве модуляторов 5-нт-6
TW200400192A (en) Chemical compounds
JP2009538910A5 (enExample)
JP2011517443A5 (enExample)
JP2017531680A (ja) 三環式アトロプ異性体の化合物
RU2006105779A (ru) Индол-5-ильные сульфонамидные производные, их получение и их применение в качестве модуляторов 5-нт-6
RU2006105778A (ru) Индол-4-ильные сульфонамидные производные, их получение и их применение в качестве модуляторов 5-нт-6
WO2007054444A3 (en) 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
HUP0202282A2 (hu) Új oktahidro-2H-pirido[1,2-a]pirazin-vegyületek, eljárás előállításukra és ezeket tartalmazó gyógyászati készítmények
JP2019535715A5 (enExample)
JP2019520411A (ja) トリプトファン2,3−ジオキシゲナーゼの阻害剤
CA2618636A1 (en) Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands
HRP20100604T1 (hr) Derivati 4h-1,2,4-triazin-5-ona, njihova priprava i njihova uporaba kao alfa 7 nikotinskih acetilkolinskih receptora
RU2006105791A (ru) Индол-7-ильные производные сульфонамида, их получение и применение в качестве лекарственных средств